Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

NCT01900431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Sarilumab
DRUG: Prednisone
DRUG: Methotrexate
DRUG: Folic/folinic acid
OTHER: Placebo (for Sarilumab)

Sponsor

Sanofi